Table 5.
Score | Compare | SE | Z | P |
---|---|---|---|---|
APACHEIII(POD1) | ||||
vs. VIS(POD1) | 0.006 | 1.197 | 0.231 | |
vs. APACHEIII(RRTt0) | 0.004 | 1.250 | 0.211 | |
vs. VIS(RRTt0) | 0.005 | 0.087 | 0.931 | |
vs. SOFA(RRTt0) | 0.006 | 0.779 | 0.438 | |
vs. SOFA(POD1) | 0.006 | 1.872 | 0.077 | |
VIS(POD1) | ||||
vs. APACHEIII(RRTt0) | 0.005 | 2.462 | 0.014* | |
vs. VIS(RRTt0) | 0.006 | 1.277 | 0.202 | |
vs. SOFA(RRTt0) | 0.006 | 0.400 | 0.689 | |
vs. SOFA(POD1) | 0.007 | 0.665 | 0.506 | |
APACHEIII(RRTt0) | ||||
vs. VIS(RRTt0) | 0.004 | 1.151 | 0.250 | |
vs. SOFA(RRTt0) | 0.004 | 2.013 | 0.044* | |
vs. SOFA(POD1) | 0.005 | 3.158 | 0.002 | |
VIS(RRTt0) | ||||
vs. SOFA(RRTt0) | 0.006 | 0.860 | 0.390 | |
vs. SOFA(POD1) | 0.006 | 1.949 | 0.051 | |
SOFA(RRTt0) | ||||
vs. SOFA(POD1) | 0.007 | 1.060 | 0.289 |
The difference is statistically significant. APACHEIII, acute physiology and health score; POD1, the first postoperative day; VIS, vasoactive-inotropic score; RRT, renal replacement therapy; RRTt0, the initiate of RRT; SOFA, sequential organ failure assessment.